European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

European equities traded in the US as American depositary receipts started the week tracking modestly higher late Monday morning, rising 0.31% to 1,970.56 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies argenx (ARGX) and DBV Technologies (DBVT), which climbed 16% and 5.1% respectively. They were followed by telecommunications company Nokia (NOK) and biopharmaceutical company Cellectis (CLLS), which advanced 2.5% and 2% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (FOCL) and internet browser company Opera (OPRA), which dropped 4.6% and 2.7% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and consumer goods company Unilever (UL), which lost 2.4% and 1.6% respectively.

The gainers from the UK were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Akari Therapeutics (AKTX), which rose 6.3% and 2.8% respectively. They were followed by biopharmaceutical companies GSK (GSK) and Bicycle Therapeutics (BCYC), which were up 1.6% and 1.5% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and communications company WPP (WPP), which fell 5.4% and 3% respectively. They were followed by alcoholic beverage company Diageo (DEO) and biopharmaceutical company NuCana (NCNA), which decreased 2.6% and 2.5% respectively.